title: Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro.
abstract: Previous studies in our laboratory have shown that proliferation of human malignant gliomas in vitro depends in part upon the activation of protein kinase C (PKC) and, conversely, can be blocked by inhibitors of PKC. Here, we examined the effect of tamoxifen, a known PKC inhibitor, on DNA synthesis and proliferation of an established human glioma line (U138) and two low passage cultures of explanted human glioblastomas. Tamoxifen produced a profound, dose-dependent inhibition of both [3H] thymidine incorporation and cell proliferation, with a 50% effective dose of 20 ng/ml under serum-free conditions and 50 to 200 ng/ml in the presence of 10% serum. These tumors were estrogen receptor negative and showed no mitogenic response to estradiol. Furthermore, concentrations of estradiol as high as 10 micrograms/ml had no effect on the tamoxifen-induced inhibition. This suggests that the mechanism of growth inhibition by tamoxifen in these gliomas did not involve an estrogen receptor-mediated process but may instead result from its inhibition of PKC. In view of the profound effect of tamoxifen on cultured gliomas at concentrations that can safely be achieved therapeutically, further in vitro and in vivo studies of this agent are warranted.
authors.affiliation: Department of Neurosurgery, University of Pittsburgh School of Medicine, Pennsylvania 15213.
authors.forename: I F
authors.initials: IF
authors.lastname: Pollack
authors.forename: M S
authors.initials: MS
authors.lastname: Randall
authors.forename: M P
authors.initials: MP
authors.lastname: Kristofik
authors.forename: R H
authors.initials: RH
authors.lastname: Kelly
authors.forename: R G
authors.initials: RG
authors.lastname: Selker
authors.forename: F T
authors.initials: FT
authors.lastname: Vertosick
mesh_terms: D002455:Cell Division / Q000187:drug effects*; D004261:DNA Replication / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004958:Estradiol / Q000494:pharmacology; D005910:Glioma / Q000473:pathology*; D006801:Humans; D066298:In Vitro Techniques; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D013629:Tamoxifen / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
chemical_list: D010982:Platelet-Derived Growth Factor; D013629:Tamoxifen; D004958:Estradiol; D011493:Protein Kinase C